S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 28.1 HKD 8.24% Market Closed
Market Cap: HK$29B

Net Margin

-143.4%
Current
Improving
by 582.7%
vs 3-y average of -726.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-143.4%
=
Net Income
¥-478.6m
/
Revenue
¥333.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-143.4%
=
Net Income
HK$-478.6m
/
Revenue
¥333.7m

Peer Comparison

Country Company Market Cap Net
Margin
CN
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
29B HKD
Loading...
US
Abbott Laboratories
NYSE:ABT
195.4B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
172.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
127.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
110.9B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
45.8B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.2B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.5B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
44.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 95% of companies in China
Percentile
5th
Based on 8 721 companies
5th percentile
-143.4%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Shanghai MicroPort MedBot Group Co Ltd
Glance View

Market Cap
29B HKD
Industry
Health Care

Shanghai MicroPort MedBot Group Co Ltd is a dynamic player in the medical innovation sector, strategically positioned at the crossroads of advanced technology and healthcare. Born out of a vision to revolutionize surgical practices, MedBot has dedicated itself to the development and commercialization of robotic-assisted systems. The company leverages cutting-edge research and development to create robotic platforms that aid surgeons in performing complex procedures with enhanced precision and control. Operating in a field where precision is paramount, MedBot's products are designed to minimize complications and reduce recovery times, catering to a global demand for improved surgical outcomes. MedBot generates its revenue by selling these sophisticated surgical robots to hospitals and healthcare institutions worldwide. Beyond the initial sale, the company benefits from offering ongoing service contracts, training, and support to ensure seamless integration and optimal performance of their products. Additionally, it capitalizes on the sale of consumables and replacement parts required for the long-term operation of their systems. Through its commitment to innovation and focus on addressing the complexities of surgical procedures, Shanghai MicroPort MedBot Group has carved out a distinctive niche, continually expanding its influence within the expanding scope of minimally invasive surgery.

Intrinsic Value
4.08 HKD
Overvaluation 85%
Intrinsic Value
Price
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-143.4%
=
Net Income
¥-478.6m
/
Revenue
¥333.7m
What is Shanghai MicroPort MedBot Group Co Ltd's current Net Margin?

The current Net Margin for Shanghai MicroPort MedBot Group Co Ltd is -143.4%, which is above its 3-year median of -726.2%.

How has Net Margin changed over time?

Over the last 3 years, Shanghai MicroPort MedBot Group Co Ltd’s Net Margin has increased from -25 015.9% to -143.4%. During this period, it reached a low of -25 015.9% on Jun 30, 2022 and a high of -143.4% on Jun 30, 2025.

Back to Top